CannabisNewsBreaks – Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Enters Exclusive Co-marketing and Distribution Agreement
Pivot Pharmaceuticals (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) this morning announced that it has entered into a definitive co-marketing and distribution agreement with S.T.U. GmbH. The Switzerland-based company manufactures and markets "Hemplix™" brand CBD oils. Per the terms of the agreement, Pivot's proprietary cannabinoid-derived products will be marketed and sold by S.T.U. online and in retail stores, where regulations permit, in the U.K., Switzerland, Germany, Austria and Italy. Pivot will distribute the Hemplix™ product line where regulations permit, and upon receiving required licenses from regulatory authorities, in Canada, Latin America and the United States. "As we continue to execute on…